Back to search
Cardiac Defect
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cardiac Defect trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Cardiac Defect trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
We hypothesize that a home monitoring program combined with routine postoperative care significantly reduces morbidity and mortality after neonatal and pediatri…
The goal of this study is to obtain specimens and data from individuals and their families with heterotaxy and related congenital heart defects in order to clar…
This prospective, multicenter, cluster-randomized controlled study aims to evaluate the accuracy of an investigational artificial intelligence (AI) Software as…
The objective of this post-market registry is to assess the clinical use of the Lifetech CeraFlex™ Closure System in a real-world and on-label fashion.
Due to successes in the last decades in pediatric heart surgery and cardiology, 90-95% of the children with congenital heart disease reach adult age.This result…
The Abbott Structural Heart (SH) Registry is being conducted to confirm the safety and performance of Abbott's SH devices in a post-market, real-world setting.…
The goal of this observational study is to develop and test a AI-based prediction model for children with perimembranous ventricular septal defect, also called…
The purpose of the study is to evaluate a peer coaching intervention in young adults with congenital heart disease.